IRMD

IRadimed Corporation [IRMD] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

IRMD Stock Summary

Top 10 Correlated Stocks

IRMD


In the News

06:20 29 Mar 2024 IRMD

IRadimed Corporation (IRMD) Q4 2023 Earnings Call Transcript

IRadimed Corporation (IRMD) Q4 2023 Earnings Call Transcript

04:05 29 Mar 2024 IRMD

IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.

WINTER SPRINGS, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 fourth quarter financial results before the market opens on Thursday, February 8, 2024. Iradimed management will host a conference call the same day beginning at 9:00 a.m. Eastern Time to discuss those results and to answer questions.

04:30 29 Mar 2024 IRMD

IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference

WINTER SPRINGS, Fla., Jan. 02, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in developing innovative Magnetic Resonance Imaging (“MRI”) compatible medical devices, today announced that the Company will be participating in the upcoming 42nd Annual J.P.

09:46 29 Mar 2024 IRMD

5 Small Hidden Gems for the Rest of 2023

We have narrowed our search to five small-cap (market capital < $1 billion) stocks. These are: HCI, LMB, IRMD, GHM, MNTX.

08:16 29 Mar 2024 IRMD

4 Top Profitable Stocks to Invest in Using Net Income Ratio

NVIDIA (NVDA), iRadimed (IRMD), Perdoceo Education (PRDO) and Axcelis Technologies (ACLS) have been selected as the top picks with a high net income ratio.

08:17 29 Mar 2024 IRMD

Top 3 Profitable Stocks to Buy Now Using Net Income Ratio

iRadimed (IRMD), PulteGroup (PHM) and NVIDIA (NVDA) have been selected as the top picks with a high net income ratio.

04:00 29 Mar 2024 IRMD

IRADIMED CORPORATION to Participate at Upcoming Investor Conferences

WINTER SPRINGS, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that the Company will be participating in two upcoming investor conferences.

10:31 29 Mar 2024 IRMD

Recent Price Trend in iRadimed (IRMD) is Your Friend, Here's Why

iRadimed (IRMD) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

09:01 29 Mar 2024 IRMD

3 Top Profitable Stocks to Invest in Using Net Income Ratio

Perdoceo Education (PRDO), Boot Barn (BOOT) and iRadimed (IRMD) have been selected as the top picks with a high net income ratio.

12:02 29 Mar 2024 IRMD

Momentum Mondays: Stocks Setting up for an Epic Dip Buying Opportunity?

Want to start the week ahead of the pack? Check out ‘Momentum Mondays,' where I cover the leading breakout stocks in the market, summarize the major events of the week ahead, and prepare investors for profitable trading.

IRMD Financial details

Company Rating
Strong Buy
Market Cap
547.54M
Income
17.19M
Revenue
65.56M
Book val./share
5.66
Cash/share
3.94
Dividend
1.68
Dividend %
3.69%
Employees
148
Optionable
No
Shortable
Yes
Earnings
02 May 2024
P/E
35.13
Forward P/E
28.94
PEG
10.54
P/S
9.11
P/B
7.69
P/C
11.16
P/FCF
151.3
Quick Ratio
7.55
Current Ratio
9.13
Debt / Equity
0.03
LT Debt / Equity
0.02
-
-
EPS (TTM)
1.36
EPS next Y
1.52
EPS next Q
0.36
EPS this Y
33.33%
EPS next Y
11.76%
EPS next 5Y
11.76%
EPS last 5Y
9.86%
Revenue last 5Y
11.22%
Revenue Q/Q
5.74%
EPS Q/Q
-10%
-
-
-
-
SMA20
3.06%
SMA50
-3.03%
SMA100
7.4%
Inst Own
39.39%
Inst Trans
0.81%
ROA
19%
ROE
23%
ROC
0.24%
Gross Margin
76%
Oper. Margin
30%
Profit Margin
26%
Payout
158%
Shs Outstand
12.66M
Shs Float
7.96M
-
-
-
-
Target Price
-
52W Range
36.12-51.037
52W High
-13.75%
52W Low
+22.19%
RSI
51.53
Rel Volume
1.15
Avg Volume
54.24K
Volume
62.16K
Perf Week
-1.3%
Perf Month
-3.85%
Perf Quarter
4.17%
Perf Half Y
1.52%
-
-
-
-
Beta
0.832
-
-
Volatility
0.74%, 1.23%
Prev Close
1.43%
Price
43.99
Change
3.19%

IRMD Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
3.142.623.394.245.2
Net income per share
0.780.110.761.021.36
Operating cash flow per share
0.830.480.910.81.07
Free cash flow per share
0.790.430.850.650.43
Cash per share
3.774.295.064.613.95
Book value per share
4.525.065.855.865.67
Tangible book value per share
4.454.985.765.75.47
Share holders equity per share
4.525.065.855.865.67
Interest debt per share
0.240.220.20.220.16
Market cap
287.02M276.42M570.52M355.4M598.26M
Enterprise value
246.5M229.06M511M299.65M550.54M
P/E ratio
29.8201.9161.1827.734.8
Price to sales ratio
7.458.7213.646.679.13
POCF ratio
28.0547.5150.6835.3944.43
PFCF ratio
29.4553.3554.2543.51109.62
P/B Ratio
5.174.57.94.828.38
PTB ratio
5.174.57.94.828.38
EV to sales
6.47.2212.225.628.4
Enterprise value over EBITDA
24.92393.0845.5319.1726.47
EV to operating cash flow
24.0939.3745.3929.8440.89
EV to free cash flow
25.2944.2148.5936.69100.87
Earnings yield
0.0300.020.040.03
Free cash flow yield
0.030.020.020.020.01
Debt to equity
0.050.040.030.030.03
Debt to assets
0.040.040.030.030.02
Net debt to EBITDA
-4.1-81.26-5.3-3.57-2.29
Current ratio
10.0612.9611.189.144.65
Interest coverage
00026.860
Income quality
1.064.251.210.780.78
Dividend Yield
0000.040.02
Payout ratio
0000.980.77
Sales general and administrative to revenue
0.270.390.230.20.23
Research and developement to revenue
0.040.060.050.040.04
Intangibles to total assets
0.010.010.010.020.03
Capex to operating cash flow
-0.05-0.11-0.07-0.19-0.59
Capex to revenue
-0.01-0.02-0.02-0.04-0.12
Capex to depreciation
-0.39-0.48-0.53-2.8-10.46
Stock based compensation to revenue
0.050.120.030.030.03
Graham number
8.943.599.9711.6113.19
ROIC
0.150.030.120.160.21
Return on tangible assets
0.150.020.110.150.19
Graham Net
3.453.934.684.683.54
Working capital
53.1M58.82M69.42M69.64M59.67M
Tangible asset value
54.66M60.42M71.06M71.6M68.9M
Net current asset value
47.76M54.05M65.54M66.35M55.27M
Invested capital
0.050.040.030.030.03
Average receivables
5.75M5.93M4.86M9.21M12.75M
Average payables
883.11K825.4K719.98K1.29M1.83M
Average inventory
3.85M3.79M4.12M4.83M9.1M
Days sales outstanding
69.1152.6544.8490.968.06
Days payables outstanding
41.1429.4529.2654.6344
Days of inventory on hand
150.77176.34160.73163.03303.8
Receivables turnover
5.286.938.144.025.36
Payables turnover
8.8712.3912.476.688.29
Inventory turnover
2.422.072.272.241.2
ROE
0.170.020.130.170.24
Capex per share
-0.04-0.05-0.06-0.15-0.64

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.181.231.281.311.38
Net income per share
0.290.270.330.40.36
Operating cash flow per share
0.240.370.280.110.31
Free cash flow per share
0.2-0.150.250.080.26
Cash per share
4.613.43.643.713.94
Book value per share
5.865.115.485.925.66
Tangible book value per share
5.694.935.295.725.46
Share holders equity per share
5.865.115.485.925.66
Interest debt per share
0.140.160.180.170.19
Market cap
355.69M495.54M601.33M559.18M599.06M
Enterprise value
299.93M455.11M557.76M514.58M551.35M
P/E ratio
24.2136.3735.9727.5932.99
Price to sales ratio
23.9332.0237.2833.8834.33
POCF ratio
117.05106.66171.14401.51153.12
PFCF ratio
138.55-259.32191.79586.35182.66
P/B Ratio
4.837.78.727.58.39
PTB ratio
4.837.78.727.58.39
EV to sales
20.1829.4134.5831.1831.59
Enterprise value over EBITDA
70.51108.62108.2987.14106.85
EV to operating cash flow
98.797.95158.74369.49140.92
EV to free cash flow
116.83-238.16177.89539.58168.11
Earnings yield
0.010.010.010.010.01
Free cash flow yield
0.0100.0100.01
Debt to equity
0.030.040.030.030.03
Debt to assets
0.030.030.030.020.02
Net debt to EBITDA
-13.11-9.65-8.46-7.55-9.25
Current ratio
9.149.078.719.134.65
Interest coverage
-9.48-11.70015.07
Income quality
0.831.360.840.270.86
Dividend Yield
0.040.03000.02
Payout ratio
3.423.88002.91
Sales general and administrative to revenue
0.180.250.220.220.24
Research and developement to revenue
0.040.050.060.030.04
Intangibles to total assets
0.020.030.030.030.03
Capex to operating cash flow
-0.16-1.41-0.11-0.32-0.16
Capex to revenue
-0.03-0.42-0.02-0.03-0.04
Capex to depreciation
0.68-35.92-2.02-2.31-3.08
Stock based compensation to revenue
0.030.030.040.030.03
Graham number
6.215.586.47.326.77
ROIC
0.040.050.050.060.05
Return on tangible assets
0.040.050.050.060.05
Graham Net
4.673.443.643.913.53
Working capital
69.64M54.54M58.51M64.05M59.67M
Tangible asset value
71.6M62.13M66.64M72.11M68.9M
Net current asset value
66.35M50.02M53.66M59.09M55.27M
Invested capital
0.030.040.030.030.03
Average receivables
11.96M12.4M11.31M11.93M12.5M
Average payables
1.38M1.78M2.15M2.67M2.32M
Average inventory
5.31M5.84M7.36M10.04M12.24M
Days sales outstanding
80.3867.0761.8369.7163.04
Days payables outstanding
44.4542.1158.2468.341.38
Days of inventory on hand
132.64151.35192.03286.34285.67
Receivables turnover
1.121.341.461.291.43
Payables turnover
2.022.141.551.322.18
Inventory turnover
0.680.590.470.310.32
ROE
0.050.050.060.070.06
Capex per share
-0.04-0.52-0.03-0.03-0.05

IRMD Frequently Asked Questions

What is IRadimed Corporation stock symbol ?

IRadimed Corporation is a US stock , located in Winter springs of Fl and trading under the symbol IRMD

What is IRadimed Corporation stock quote today ?

IRadimed Corporation stock price is $43.99 today.

Is IRadimed Corporation stock public?

Yes, IRadimed Corporation is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated Stocks
Similar Market Cap